P1207: MULTICENTER RANDOMIZED CONTROLLED (COMPARATIVE) OPEN PROSPECTIVE STUDY TO EVALUATE THE EFFICACY OF THE R-DA-EPOCH-21 AND R-MNHL-BFM-90 ± AUTO- HSCT PROGRAMS IN PATIENTS WITH DE NOVO DIFFUSE B-CELL LAR
Main Authors: | A. Magomedova, S. Kravchenko, A. Misyurina, Y. Mangasarova, O. Margolin, E. Fastova, F. Babaeva, L. Gorenkova, M. Bagova, E. Nesterova, K. Sychevskaya, T. Moiseeva, A. Kovrigina, T. Obukhova, V. Dvirnyk, I. Galtseva, V. Galuzyak, S. Maryina, K. Danishyan, I. Kostina, A. Sudarikov, G. Klyasova, S. Kulikov, Y. Chabaeva, E. Zinina, I. Kryuchkova, S. Sizikova, V. Sergeyevicheva, T. Ksenzova, E. Anikina, T. Shelekhova, O. Arzhanukhina, K. Kaplanov, T. Konstantinova, O. Serdyuk, T. Sychyova, T. Chagorova, I. Nechunayeva, L. Anchukova, O. Dzarasova, E. Parovichnikova, V. Savchenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000847692.97408.4c |
Similar Items
-
Comparative assessment of efficacy and toxicity of R-DA-EPOCH and R-mNHL-BFM-90 induction courses in the treatment of patients with diffuse large B-cell lymphoma with poor prognostic factors in a randomized multicenter clinical trial “DLBCL-2015”
by: M. O. Bagova, et al.
Published: (2021-09-01) -
PB2089: ALGORITHM FOR SEVERE COVID-19 RISK STRATIFICATION DEPENDING MONOCLONAL ANTI-CD20 ANTIBODIES TREATMENT DURATION IN NON-HODGKIN LYMPHOMA PATIENTS.
by: K. Sychevskaya, et al.
Published: (2022-06-01) -
MEVLÂNA CELÂLEDDİN RÛMÎ (1207-1273)
by: Sâfi Arpaguş
Published: (2007-12-01) -
1207 Update on Progress of the Mesenchymal Stromal Cell Trial in Refractory Lupus
by: R Martin, et al.
Published: (2022-12-01) -
THE FREQUENCY OF ALLELIC VARIANTS OF GENES TNFRI AT POSITIONS -609 AND -1207 AND TNFRII AT POSITIONS -1709 AND -3609 IN HEALTHY DONORS AND PATIENTS WITH RHEUMATOID ARTHRITIS
by: N. S. Shkaruba, et al.
Published: (2012-05-01)